全文获取类型
收费全文 | 1120篇 |
免费 | 42篇 |
国内免费 | 5篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 49篇 |
妇产科学 | 73篇 |
基础医学 | 137篇 |
口腔科学 | 22篇 |
临床医学 | 56篇 |
内科学 | 427篇 |
皮肤病学 | 3篇 |
神经病学 | 45篇 |
特种医学 | 20篇 |
外科学 | 158篇 |
预防医学 | 31篇 |
眼科学 | 6篇 |
药学 | 55篇 |
中国医学 | 5篇 |
肿瘤学 | 79篇 |
出版年
2023年 | 9篇 |
2022年 | 12篇 |
2021年 | 25篇 |
2020年 | 15篇 |
2019年 | 12篇 |
2018年 | 22篇 |
2017年 | 16篇 |
2016年 | 22篇 |
2015年 | 21篇 |
2014年 | 37篇 |
2013年 | 46篇 |
2012年 | 86篇 |
2011年 | 75篇 |
2010年 | 50篇 |
2009年 | 70篇 |
2008年 | 64篇 |
2007年 | 95篇 |
2006年 | 79篇 |
2005年 | 70篇 |
2004年 | 80篇 |
2003年 | 68篇 |
2002年 | 46篇 |
2001年 | 5篇 |
2000年 | 8篇 |
1999年 | 10篇 |
1998年 | 4篇 |
1997年 | 9篇 |
1996年 | 8篇 |
1995年 | 7篇 |
1994年 | 5篇 |
1993年 | 4篇 |
1992年 | 4篇 |
1991年 | 3篇 |
1990年 | 5篇 |
1989年 | 3篇 |
1988年 | 4篇 |
1987年 | 7篇 |
1986年 | 4篇 |
1985年 | 3篇 |
1984年 | 10篇 |
1983年 | 9篇 |
1982年 | 7篇 |
1981年 | 5篇 |
1980年 | 6篇 |
1978年 | 2篇 |
1974年 | 2篇 |
1968年 | 2篇 |
1924年 | 2篇 |
1922年 | 1篇 |
1906年 | 1篇 |
排序方式: 共有1167条查询结果,搜索用时 31 毫秒
101.
De Conti F Piovesana P Nicolosi G Lafisca N Mantovani E Viena P Pantaleoni A 《Echocardiography (Mount Kisco, N.Y.)》1997,14(4):387-392
Systolic anterior motion of the mitral valve (MV) with dynamic left ventricular (LV) outflow tract obstruction is a well known phenomenon in hypertrophic cardiomyopathy, or other forms of hyper-dynamic LV function associated with hypovolemic states, or LV hypertrophy. We report three patients with MV prolapse in the absence of the above predisposing factors, who developed an LV outflow dynamic gradient during acute transient myocardial ischemia. An interaction between structural abnormalities of the mitral apparatus and ischemia-dependent LV shape deformity most likely accounted for the outflow gradient. 相似文献
102.
103.
Carlo Trani MD Antonella Tommasino MD Maura Giammarinaro MD Francesco Burzotta MD Santiago Federico Coroleu MD Vittoria Rufini MD Mario Attilio Mazzari MD Italo Porto MD Giampaolo Niccoli MD Antonio Maria Leone MD Rocco Mongiardo MD Francesca Augusta Gabrielli MD Giovanni Schiavoni MD Giancarlo Biamino MD Filippo Crea MD 《Catheterization and cardiovascular interventions》2010,76(1):26-34
Objectives : To investigate the role of renal stenting in selected patients with chronic ischemic heart disease and renal artery stenosis. Methods : Consecutive patients, with chronic ischemic heart disease and severe hypertension and/or impaired renal function undergoing renal stenting, were prospectively enrolled. Mid‐term (at least 2 years) follow‐up was performed to assess both changes in renal function [serum creatinine and estimated glomerular filtrate rate (eGFR)] and blood pressure (BP) control (number of required drugs) and to record the incidence of clinical major adverse events. Moreover, in the first consecutive 24 patients, out‐of‐range pressure values at 24‐hr BP monitoring and GFR at renal scintigraphy were measured at baseline and 1 month after stenting. Results : Seventy patients treated by stenting on 86 renal arteries entered the study. Procedural success rate was 99% and no major complication occurred. At 2‐year follow‐up, both mean serum creatinine (?0.1 ± 0.7 mg/dl at follow‐up compared to baseline, P = 0.6) and eGFR (+3.7 ± 23.5 ml/min/1.73m2 at follow‐up compared to baseline, P = 0.2) did not significantly change while the number of drugs required to control BP significantly decreased (2.7 ± 0.8 to 2.2 ± 0.7, P < 0.0001). In the subset of 24 patients evaluated at 1 month, GFR significantly increased (62 ± 20 ml/min to 67 ± 21 ml/min; P = 0.008) and the rate of the out‐of‐range systolic pressure values at 24‐hr monitoring significantly decreased (51–33%, P = 0.005). Elevated baseline creatinine values and the presence of global renal ischemia were identified as predictors of poor outcome at the multivariate analysis. Conclusions : In selected patients with chronic ischemic heart disease and hypertension and/or renal insufficiency, renal stenting may be performed with very low periprocedural complications and results in unchanged renal function and improved BP control. © 2010 Wiley‐Liss, Inc. 相似文献
104.
105.
106.
107.
108.
Carmelo D’Arrigo Attilio Speranza Edoardo Monaco Alessandro Carcangiu Andrea Ferretti 《Journal of orthopaedics and traumatology》2009,10(1):47-54
Background The tissue sparing surgery (TSS) concept means not only smaller incisions but also less tissue disruption, allowing decreased
blood loss and improved function. However, TSS techniques can result in more complications related to the learning curve.
The aim of this study was to compare the learning curve of an experienced surgeon with different TSS approaches for total
hip replacement (THR) from a clinical and surgical point of view, focussing especially on complications related to the use
of different geometric stems.
Materials and methods Sixty patients scheduled to be operated for a primary THR were enrolled in the study and were randomly assigned to surgery
by one of three different TSS approaches: lateral with mini incision (group A), minimally invasive anterior (group B) and
minimally invasive antero-lateral (group C). Results from the three TSS groups were compared with a control group of 149 patients
(group D).
Results Our results reveal significantly reduced blood loss in the TSS groups compared with the control group, with no differences
between the TSS groups. We found better early functional scores in the two minimally invasive groups (anterior and anterolateral),
and a lower rate of complications with the antero-lateral TSS approach.
Conclusion The antero-lateral TSS approach seems to be safer and less demanding than standard THR surgery, and is suitable for use with
different stems. 相似文献
109.
Francesco Onorati Giuseppe Santarpino Gelsomina Tangredi Giorgio Palmieri Antonino S. Rubino Daniela Foti Elio Gulletta Attilio Renzulli 《European journal of cardio-thoracic surgery》2009,35(6):1012-1019
Objective: Intra-aortic balloon pump (IABP)-induced pulsatile perfusion has demonstrated that it can preserve organ function during cardiopulmonary bypass (CPB). We evaluated the role of IABP pulsatile perfusion on endothelial response. Methods: Forty consecutive isolated CABG undergoing preoperative IABP were randomized to receive IABP pulsatile CPB during aortic cross-clamping (group A, 20 patients) or standard linear CPB (group B, 20 patients) during cross-clamp time. Hemodynamic results were analyzed by Swan-Ganz catheter [mean arterial pressure (MAP), cardiac index (CI), indexed systemic vascular resistances (ISVR), indexed pulmonary vascular resistances (IPVR), wedge pressure (PCWP)]. Inflammatory/endothelial response was analyzed by pro-inflammatory (IL-2, IL-6, IL-8), anti-inflammatory cytokines (IL-10), and endothelial markers [vascular endothelial growth factor (VEGF) and monocyte chemotactic protein-1 (MCP-1)]. All measurements were recorded preoperatively (T0), before aortic declamping (T1), at the end of surgery (T2), 12 h (T3) and 24 h (T4) postoperatively. ANOVA for repeated measures was used to evaluate the differences of means. Results: Hemodynamic response was comparable except for higher MAP (p = 0.01 at T1) and lower ISVR (p = 0.001 at T1, p = 0.003 at T2) in group A. No differences were found in perioperative leakage of IL-2, IL-6, and IL-8 between the two groups (within-group p = 0.0001 either in group A and group B; between-groups p = NS at 2-ANOVA). Group A showed significantly lower VEGF (between-groups p = 0.001 at 2-ANOVA, p = 0.001 at T1, T2) and MCP-1 (between-groups p = 0.001 at 2-ANOVA, p = 0.001 at T1, T2) with higher IL-10 secretion (between-groups p = 0.001 at 2-ANOVA, p = 0.01 at T1, T2, T3). Conclusions: IABP-induced pulsatile perfusion allows lower endothelial activation during CPB and higher anti-inflammatory cytokines secretion. 相似文献
110.
Pieroni M Bellocci F Sanna T Verardo R Ierardi C Maseri A Frustaci A Crea F 《Journal of cardiac failure》2007,13(5):380-388
BackgroundHypertrophic cardiomyopathy (HCM) is associated with increased plasma brain natriuretic peptide (BNP), but sequential plasma and myocardial BNP assessment in stable and dilated HCM has never been performed.Methods and ResultsForty consecutive HCM patients (42 ± 8 years, 25 males) underwent cardiac catheterization, angiography, and left ventricular (LV) endomyocardial biopsy. During follow-up (70.5 ± 6.7 months), 30 patients (Group 1) remained stable whereas 10 patients (Group 2) progressed to dilated phase. Group 2 patients underwent a second invasive study with LV biopsy. BNP plasma levels were measured at baseline and at follow-up in all patients. All biopsies were processed for histology and immunohistochemistry with anti-BNP antibodies. BNP plasma levels remained unchanged in Group 1, whereas it significantly increased in all Group 2 patients who exhibited an elevation of LV and right ventricular end-diastolic pressure. Immunohistochemistry showed an increase of BNP-positive myocytes in follow-up biopsies when compared with baseline (75.0 ± 15.0 % versus 29.8 ± 10.0 %; P = .005) with a significant correlation with LV end-diastolic pressure (r = 0.78, P < .001) and plasma BNP (r = 0.83, P < .001).ConclusionsProgression to end-stage of HCM is characterized by further increase of myocardial and plasma BNP. Serial assessment of plasma BNP may provide noninvasive recognition of hemodynamic deterioration, allowing prompt institution of heart failure therapy. 相似文献